
Rating Update: Stock Rating C-High Neutral (1/31/19)-Eagle Pharmaceuticals Inc (EGRX).
BUSINESS Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers argatroban for heparin-induced thrombocytopenia; Ryanodex […]